Cargando…
P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429228/ http://dx.doi.org/10.1097/01.HS9.0000846364.74016.03 |
| _version_ | 1784779373891551232 |
|---|---|
| author | Grandclement, C. Estoppey, C. Dheilly, E. Panagopoulou, M. Martini, E. Labanca, V. De Angelis, S. Frei, J. Drake, A. Rubod, A. Gudi, G. Udupa, V. Koch Olsen, J. Giovannini, R. Doucey, M. A. Feldman, E. Konto, C. Srivastava, A. Perro, M. Sammicheli, S. |
| author_facet | Grandclement, C. Estoppey, C. Dheilly, E. Panagopoulou, M. Martini, E. Labanca, V. De Angelis, S. Frei, J. Drake, A. Rubod, A. Gudi, G. Udupa, V. Koch Olsen, J. Giovannini, R. Doucey, M. A. Feldman, E. Konto, C. Srivastava, A. Perro, M. Sammicheli, S. |
| author_sort | Grandclement, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429228 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94292282022-08-31 P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES Grandclement, C. Estoppey, C. Dheilly, E. Panagopoulou, M. Martini, E. Labanca, V. De Angelis, S. Frei, J. Drake, A. Rubod, A. Gudi, G. Udupa, V. Koch Olsen, J. Giovannini, R. Doucey, M. A. Feldman, E. Konto, C. Srivastava, A. Perro, M. Sammicheli, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429228/ http://dx.doi.org/10.1097/01.HS9.0000846364.74016.03 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Grandclement, C. Estoppey, C. Dheilly, E. Panagopoulou, M. Martini, E. Labanca, V. De Angelis, S. Frei, J. Drake, A. Rubod, A. Gudi, G. Udupa, V. Koch Olsen, J. Giovannini, R. Doucey, M. A. Feldman, E. Konto, C. Srivastava, A. Perro, M. Sammicheli, S. P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES |
| title | P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES |
| title_full | P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES |
| title_fullStr | P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES |
| title_full_unstemmed | P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES |
| title_short | P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES |
| title_sort | p871: isb 1442, a first-in-class cd38 and cd47 bispecific antibody innate cell modulator for the treatment of cd38 positive hematological malignancies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429228/ http://dx.doi.org/10.1097/01.HS9.0000846364.74016.03 |
| work_keys_str_mv | AT grandclementc p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT estoppeyc p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT dheillye p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT panagopouloum p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT martinie p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT labancav p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT deangeliss p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT freij p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT drakea p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT ruboda p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT gudig p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT udupav p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT kocholsenj p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT giovanninir p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT douceyma p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT feldmane p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT kontoc p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT srivastavaa p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT perrom p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies AT sammichelis p871isb1442afirstinclasscd38andcd47bispecificantibodyinnatecellmodulatorforthetreatmentofcd38positivehematologicalmalignancies |